SCHEMBL23199043

SCHEMBL23199043

Cc1ccc2cc3cc(O)ccc3cc2c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.49
ESR1 P03372 6/20 0.46
ESR2 Q92731 6/20 0.46
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
HIF1A Q16665 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
ACHE P22303 1/20 0.38
ABL1 P00519 1/20 0.38
ABCB1 P08183 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29771818 0.86 ESR1 (0.46) DYRK1AESR1ESR2CYP1A2CYP3A4
SCHEMBL17445867 0.86 ESR1 (0.46) DYRK1AESR1ESR2CYP1A2CYP3A4
SCHEMBL30845731 0.84 CYP1A2 (0.46) CYP1A2TSHRHIF1AHSD17B10TDP1
SCHEMBL787068 0.84 CYP1A2 (0.46) CYP1A2TSHRHIF1AHSD17B10TDP1
SCHEMBL17445866 0.84 MCL1 (0.46) DYRK1AESR1ESR2CYP1A2CYP3A4
SCHEMBL2770679 0.80 CYP1A2 (0.46) DYRK1AESR1ESR2CYP1A2CYP3A4
SCHEMBL2773224 0.80 CYP1A2 (0.46) DYRK1AESR1ESR2CYP1A2CYP3A4
SCHEMBL11054996 0.79 CYP1A2 (0.55) DYRK1AESR1ESR2CYP1A2CYP3A4
SCHEMBL31433385 0.78 DYRK1A (0.54) DYRK1AESR1ESR2CYP1A2CYP3A4
SCHEMBL28142951 0.78 DYRK1A (0.43) DYRK1AESR1ESR2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3801507-A2 TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION ETH Zurich (CH) 2021-04-14 EP claimed